Mounjaro doses: which strength is right for you?

Why the starting dose and your eventual dose are two different conversations

A question our prescribers hear most weeks is some version of: "I've seen people talk about 15mg online, why can't I just start there?" The short answer is that 2.5mg is designed to settle your system, not to treat weight. Jumping straight to a higher strength dramatically increases the chance of nausea, vomiting and digestive discomfort that could push you off the treatment entirely. The titration schedule (moving up roughly every four weeks) exists because your gut needs time to adapt to tirzepatide's effect on gastric emptying and appetite signalling.

This is worth sitting with, because it changes how you think about early weeks. If 2.5mg feels underwhelming, that's intentional. Progress on Mounjaro is measured over months, not the first pen. Our Mounjaro overview covers the full mechanism if you want to understand what's happening biologically during that adjustment window.

Your prescriber's job at each review is to weigh two things: are you tolerating the current dose comfortably, and is your body responding? Both matter. Someone sailing through on 7.5mg with good results may stay there rather than push to 10mg. Someone struggling with persistent nausea at 5mg may pause the increase rather than push through. If you want to read about how each step up is structured, our page on the different doses of Mounjaro explains what changes at each stage. Titration is a clinical conversation, not a conveyor belt.

What the evidence says about higher doses, and what it doesn't

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, adults taking tirzepatide 15mg for 72 weeks lost around 20–21% of their body weight on average. That is the headline figure you'll see quoted widely. What gets less attention is that 10mg and 12.5mg produced meaningfully significant results too, and the trial population covered thousands of adults across a broad range of starting weights and health profiles.

The takeaway is not that 15mg is the only dose worth having. It is that higher doses tended to produce greater average weight loss across the trial group, while individual responses varied considerably. NICE's appraisal of tirzepatide (published as TA1026) notes that if someone hasn't lost at least 5% of their body weight after six months at the highest tolerated dose, continuing treatment should be reviewed. That phrasing matters: the highest dose you can tolerate, not the highest dose that exists.

For a deeper look at how tirzepatide's strengths compare in practice, our page covering what the doses of tirzepatide are covers the clinical context in more detail, alongside this page on tirzepatide strengths.

Side effects, tolerability and what shapes the pace of your increases

Dose increases are the moments when side effects are most likely to flare. Nausea, loose stools, indigestion and fatigue are most common in the days immediately after moving up a step, and for most people they settle within one to two weeks as the body adjusts. Staying well hydrated and eating smaller meals during that window helps considerably.

More serious symptoms (severe stomach pain that spreads to the back, signs of an allergic reaction, or symptoms suggesting gallbladder trouble) need prompt medical attention regardless of which dose you're on. The NHS tirzepatide medicines page sets out the full side-effect picture clearly and is worth reading before you start.

One practical point: oral contraceptives may be absorbed less reliably during the first four weeks on any dose and for four weeks after each increase, because Mounjaro slows how quickly your stomach empties. Adding a non-oral method of contraception during those windows is the standard clinical recommendation. Your prescriber will flag this, but it's useful to know ahead of your first review.

If you're weighing up what private treatment involves more broadly, our Mounjaro cost page explains what a legitimate price should include.

Who decides when you go up, and when to stay put

This is the part that surprises some people: dose decisions are never yours alone to make. Each increase requires a clinical review. At nume, that means your responses are read by a GPhC-registered Independent Prescriber before your next supply is issued. Evidence of how you're getting on (including weight check-ins) feeds into every repeat. No automated approval, no rubber-stamping.

There are legitimate reasons to stay at a lower dose for longer than the standard schedule suggests: persistent side effects, a period of illness, upcoming surgery (your clinical team needs to know you're on Mounjaro before any procedure), or simply that a lower dose is working well. There are also reasons a prescriber might recommend pausing an increase rather than pushing through. If you want a clear breakdown of each strength available, our page on what the doses of Mounjaro are is a useful reference. The schedule is a guide, not a rule.

If you're still deciding whether Mounjaro is the right option for you, our weight-loss treatment overview sets out how it sits alongside other licensed options. And if you have specific questions about the dosing schedule that aren't answered here, our FAQs cover many of the most common ones.